# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-25-001846
Filing Date
2025-03-25
Accepted
2025-03-25 08:00:28
Documents
6
Period of Report
2025-03-25

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | REPORT OF FOREIGN PRIVATE ISSUER | ea0235561-6k_alterity.htm | 6-K | 14210
2 | CEASING TO BE A SUBSTANTIAL HOLDER | ea023556101ex99-1_alterity.htm | EX-99.1 | 10303
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 485043
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 360055
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 96425
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 541555
| Complete submission text file | 0001013762-25-001846.txt |  | 2067819

Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 25765904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)